Cargando…

Development and validation of a risk stratification nomogram for predicting prognosis in bone metastatic breast cancer: A population-based study

Bone metastasis seriously affects the survival of breast cancer. Therefore, the study aimed to explore the independent prognostic factors in bone metastatic breast cancer (BMBC) and to construct a prognostic nomogram that can accurately predict the survival of BMBC and strictly divide the patients i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Niuniu, Yi, Jun, Wang, Zhe, Yang, Lu, Wu, Ying, Huang, Meiling, Hou, Guangdong, Ling, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545337/ https://www.ncbi.nlm.nih.gov/pubmed/33578627 http://dx.doi.org/10.1097/MD.0000000000024751

Ejemplares similares

Prognostic nomogram for female patients suffering from non-metastatic Her2 positive breast cancer: A SEER-based study
por: Wu, Jiangwen, et al.
Publicado: (2022)

Prognostic significance of preoperative albumin to fibrinogen ratio associated nomograms in patients with breast invasive ductal carcinoma
por: Zheng, Lihua, et al.
Publicado: (2020)

Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016)

Construction and validation of a transient receptor potential-related long noncoding RNA signature for prognosis prediction in breast cancer patients
por: Guo, Qiaonan, et al.
Publicado: (2023)

Preoperative predictive factors affecting sentinel lymph node positivity in breast cancer and comparison of their effectiveness with existing nomograms
por: Ceylan, Cengiz, et al.
Publicado: (2022)

Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc
por: Cui, Jianxiu, et al.
Publicado: (2019)

Identification of an optimized glycolytic-related risk signature for predicting the prognosis in breast cancer using integrated bioinformatic analysis
por: Jiang, Di, et al.
Publicado: (2023)

Expression and prognosis analysis of GINS subunits in human breast cancer
por: Li, Hongtao, et al.
Publicado: (2021)

Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer
por: Yao, Juan, et al.
Publicado: (2017)

Prognosis and clinicopathological characteristics of metaplastic breast cancer: A meta-analysis
por: Yang, Xiaolu, et al.
Publicado: (2022)

Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer: A SEER-based study
por: Li, Yang, et al.
Publicado: (2021)

Physical and psychological effects of different temperature-controlled breast prostheses on patients with breast cancer during rehabilitation: a randomized controlled study (CONSORT)
por: Qiu, Jiajia, et al.
Publicado: (2020)

Clinicopathologic features of single bone metastasis in breast cancer
por: Karatas, Murat, et al.
Publicado: (2021)

Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis
por: Park, Soyeon, et al.
Publicado: (2017)

Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis
por: Zhao, Xiao-Bo, et al.
Publicado: (2016)

A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis
por: Xing, Tengfei, et al.
Publicado: (2023)

Association Between Histone Methyltransferase hSETD1A and Prognosis in Patients With Triple-Negative Breast Cancer After Surgery: A Retrospective Study in the Chinese Female Population
por: Zhu, YanYan, et al.
Publicado: (2016)

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
por: Baretta, Zora, et al.
Publicado: (2016)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis
por: Sheng, Zhijuan, et al.
Publicado: (2020)

LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA)
por: Jin, Tong Yi, et al.
Publicado: (2021)

Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis
por: Liu, Shuyu, et al.
Publicado: (2020)

Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population
por: Xia, Zongjiang, et al.
Publicado: (2016)

Discordance of immunohistochemical markers between primary and recurrent or metastatic breast cancer: A retrospective analysis of 107 cases
por: Peng, Li, et al.
Publicado: (2020)

Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report
por: Barchiesi, Giacomo, et al.
Publicado: (2019)

A new strategy for the treatment of heavily pretreated metastatic breast cancer: A case report and review of the literature
por: Ge, Ting-Ting, et al.
Publicado: (2023)

Establishment of a 6-signature risk model associated with cellular senescence for predicting the prognosis of breast cancer
por: Zhang, Xiu-Xia, et al.
Publicado: (2023)

Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer
por: Al-Muqbel, Kusai M., et al.
Publicado: (2016)

Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report
por: Dai, Jiali, et al.
Publicado: (2020)

Real-world effectiveness and sensitivity of palbociclib plus endocrine therapy in HR+/HER2– patients with metastatic breast cancer
por: Li, Jingping, et al.
Publicado: (2021)

Identification and validation of molecular subtypes and a 9-gene risk model for breast cancer
por: Feng, Jiexin
Publicado: (2023)

Association between serum cytokines and progression of breast cancer in Chinese population
por: Wang, Haiyan, et al.
Publicado: (2017)

Anemia and thrombocytopenia as initial symptoms of occult breast cancer with bone marrow metastasis: A case report
por: Liu, Lulu, et al.
Publicado: (2017)

Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysis
por: Xu, Han-Xiao, et al.
Publicado: (2016)

Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestane
por: Krasniqi, Eriseld, et al.
Publicado: (2020)

Change of HER2 status during disease recurrence predicts good prognosis for primary squamous cell carcinoma of the breast: A case report
por: Cao, Yong, et al.
Publicado: (2019)

Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis
por: Ding, Yunfeng, et al.
Publicado: (2021)

Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment
por: Watanuki, Rurina, et al.
Publicado: (2020)

Manual lymphatic drainage for lymphedema in patients after breast cancer surgery: A systematic review and meta-analysis of randomized controlled trials
por: Liang, Mining, et al.
Publicado: (2020)

Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab
por: Wang, Xinle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qishsda1rbmdun68q1hr82qta5